Among CMV‐positive renal transplant patients receiving non‐T‐cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients-Reference-Cited by-同舟云学术

Among CMV‐positive renal transplant patients receiving non‐T‐cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients

Published:2021-02-18 Issue:3 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl. Infect. Dis.

Author:

Boulay Hugoline¹²^ORCID,Oger Emmanuel³,Cantarovich Diego⁴,Gatault Philippe⁵,Thierry Antoine⁶,Le Meur Yannick⁷^ORCID,Duveau Agnès⁸,Vigneau Cécile¹²,Lorcy Nolwenn¹

Affiliation:

1. Service de Néphrologie CHU Pontchaillou Rennes France

2. Inserm EHESP Irset (Institut de Recherche en Santé, Environnement et Travail) UMR_S 1085 Univ Rennes Rennes France

3. Service de Pharmacologie clinique et biologique CHU Pontchaillou Rennes France

4. Institut de Transplantation Urologie‐Néphrologie Centre Hospitalier Universitaire de Nantes Nantes France

5. Service de Néphrologie et Immunologie Clinique Centre Hospitalier Universitaire de Tours Tours France

6. Service de Néphrologie Hémodialyse et Transplantation RénaleCentre Hospitalier Universitaire de Poitiers Poitiers France

7. Service de Néphrologie Centre Hospitaliser de BrestUniversité de Bretagne Occidentale Brest France

8. Service de Nephrologie‐Dialyse‐Transplantation Centre Hospitalier Universitaire d'Angers Angers France

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13541

Reference32 articles.

1. Cytomegalovirus in Solid Organ Transplantation

2. Effets du cytomégalovirus en transplantation et place de la prophylaxie antivirale

3. Viral Infection after Renal Transplantation: Surveillance and Management: Figure 1.

4. Cytomegalovirus Disease in Kidney Transplant Recipients: Incidence, Clinical Profile, and Risk Factors

5. Cytomegalovirus Disease Amongst Renal Transplant Recipients in Australia and New Zealand

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study;Clinical and Experimental Nephrology;2024-04-13

2. Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients;Progress in Transplantation;2021-11-27

3. Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab;International Journal of Infectious Diseases;2021-06

4. Among CMV‐positive renal transplant patients receiving non‐T‐cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients;Transplant Infectious Disease;2021-02-18